Inventor
ANNA VULPETTI
Inventor
CH
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
Y02PClimate change mitigation technologies in the production or processing of goods12%
PatentTitleYear
12,441,733Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of bruton's tyrosine kinase inhibitors202511,673,868Amino pyrimidine derivatives202311,613,543Substituted pyrrolo[2,3-d]pyrimidines as Bruton's Tyrosine Kinase inhibitors202311,541,0563-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivatives202311,180,460Amino pyrimidine derivatives2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to NOVARTIS AG (5)· patent assignee history
2021–2025Based in CH· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 5 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CH | 5 | 2021–2025 |